Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome

PURPOSE: Type 1 hepatorenal syndrome (type 1 HRS) or hepatorenal syndrome-acute renal injury (HRS-AKI) leads to high short-term mortality rates in patients with cirrhosis. Vasoconstrictor therapy effectively improves survival of these patients and has been a bridge to liver transplantation. The aim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clinicoecon Outcomes Res
Autori principali: Sangroongruangsri, Sermsiri, Kittrongsiri, Kankamon, Charatcharoenwitthaya, Phunchai, Sobhonslidsuk, Abhasnee, Chaikledkaew, Usa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8328389/
https://ncbi.nlm.nih.gov/pubmed/34349534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S317390
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi